Navigation Links
Lo studio EXAMINE della Takeda sulla sicurezza cardiovascolare di alogliptin in aggiunta alla terapia standard ha soddisfatto l'endpoint primario di non inferiorità rispetto al placebo dimostrando che non si verifica nessun incremento del rischio ca
Date:9/17/2013

ia, pancreatite, tumori maligni e i risultati degli esami di laboratorio. I tassi di ipoglicemia, tumore maligno, pancreatite, dialisi e un innalzamento dell'amino-transferasi sierica sono stati simili per i gruppi alogliptin e placebo. Nel corso dello studio non sono stati riportati casi di cancro del pancreas. I gruppi alogliptin e placebo non hanno evidenziato differenze significative relativamente ai tassi degli eventi avversi seri (rispettivamente 33,6% e 35,5%, p=0,14).

Informazioni su EXAMINE
EXAMINE , uno studio clinico globale, di grandi dimensioni, randomizzato, in doppio cieco, controllato con placebo, è stato concepito per valutare la sicurezza cardiovascolare del trattamento con alogliptin in aggiunta al trattamento standard, in confronto al placebo in aggiunta al trattamento standard solamente, in pazienti affetti da diabete di tipo 2 e una sindrome coronarica acuta (ACS) recente (da 15 a 90 giorni prima della randomizzazione). Lo studio aveva un endpoint primario composito di morti per cause cardiovascolari, infarto miocardico non fatale e ictus non fatale.

Nel gruppo trattato con alogliptin, il 71,4% dei pazienti è stato trattato con 25 mg, il 25,7% con 12,5 mg, e il 2,9% con 6,25 mg di alogliptin al giorno. I dosaggi di alogliptin sono stati determinati in base alla funzionalità renale: tasso di filtrazione glomerulare stimato (eGFR) secondo la formula della "Modification in Diet in Renal Disease" > 60 ml/min, 25 mg giornalieri; < 60 ml/min ma > 30 ml/min, 12,5 mg giornalieri; e < 30 ml/min, 6,25 mg giornalieri. L'interruzione prematura del farmaco in studio è stata simile nei gruppi alogliptin e placebo (20,9% dei pazienti rispetto a 22,6%). La durata mediana dell'esposizione al farmaco in studio è stata di 533 giorni (range interquartile, 280 - 751 giorni). Al termine dello studio, la variazione media di HbA1c dal basale è stata pari a -0,33% e 0,03% rispettivamente nel gr
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Anthony Creed Joins DDSTUDIO As GM, Experience Design
2. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
3. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
4. I benefici della tecnologia Hologic per lutilizzo della Tomosintesi in vengono corroborati dalla pubblicazione di uno studio italiano
5. Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
6. River City Laser Tattoo Removal Studio Offers Grand Opening Discounts on Treatments Using the Astanza Revolution Laser
7. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
8. New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments
9. Study Examines Smart Pharma Strategies for Effective Messaging around New Products and the Medical Conditions they Treat
10. TeamHealth White Paper Examines Telemedicine Risks, Risk Management Strategies
11. The Food Journal Examines Dietary Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  Hologic, Inc. (NASDAQ: ... and Chief Executive Officer, will present at the Morgan Stanley ... , New York on Tuesday, September ... parties are invited to listen to the live audio webcast ... at www.hologic.com/investors-overview . An archive of the presentation will ...
(Date:9/2/2014)... SEATTLE , Sept. 2, 2014 /PRNewswire/ ... company committed to the development and commercialization ... today announced an update on corporate and ... structure, commitment for future funding, ongoing clinical ... In corporate news, Chief Executive Officer ...
(Date:9/2/2014)...  BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a ... XIAFLEX ® in the U.S. and XIAPEX ® ... Wegman , will present at the following upcoming investor conferences. ... & Renshaw 16 th Annual Global Investment Conference ... 9, 2014 at 9:10 a.m. EDT , Aegis ...
Breaking Medicine Technology:VentiRx Pharmaceuticals Provides Corporate and Clinical Update 2VentiRx Pharmaceuticals Provides Corporate and Clinical Update 3BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2
... (NASDAQ: AMRI ), a global contract services organization ... as part of its ongoing global operations review to improve ... its European operations focused on a reduction of the workforce ... at its Budapest, Hungary operation. As a ...
... Jan. 9, 2012  Xenon today announced a strategic alliance ... RO, ROG; OTCQX: RHHBY), to discover and develop compounds ... "We are delighted to be collaborating with ... "Genentech is among the world,s leading biotech companies and ...
Cached Medicine Technology:AMRI Announces Review of Its Hungary Operation 2AMRI Announces Review of Its Hungary Operation 3Xenon to Collaborate with Genentech on Discovery of Novel Targeted Pain Therapeutics 2
(Date:9/2/2014)... 02, 2014 Welcome to Arthritis ... 4.6 million Canadians living with the disease, The Arthritis ... Arthritis” video series featuring well-known Canadians from different walks ... ,      Lloyd Robertson , veteran news anchor ... skier ,      Amy Cotton , two-time ...
(Date:9/2/2014)... prevalence of opioid-involved overdoses has become an increasing concern ... to the New York City Department of Health and ... in 2011 was nearly triple the number of such ... attributed to a dramatic rise in nonmedical prescription opioid ... recently, in heroin use among youth who transitioned from ...
(Date:9/2/2014)... research studies have made it clear that a mother,s ... lactation have a profound impact on her offspring and ... However, until now, the mechanisms behind this phenomenon were ... 2014 issue of The FASEB Journal F ... link between a mother,s diet and an offspring,s risk ...
(Date:9/2/2014)... PA (PRWEB) September 02, 2014 ... communications and education, is proud to announce the acquisition ... clinical resource center designed for healthcare professionals who integrate ... offers practitioners comprehensive access to:, , ... Dedicated topic centers for diabetes, oncology, renal ...
(Date:9/2/2014)... ROCHESTER, Minn. How well patients recover from ... their medical conditions and the operations themselves. Family ... risk of surgical complications, a Mayo Clinic study ... operation may reduce patients, stress, speed their recoveries ... The study specifically looked at colon cancer patients, ...
Breaking Medicine News(10 mins):Health News:‘Voices of Arthritis’ Launches Awareness Month 2Health News:‘Voices of Arthritis’ Launches Awareness Month 3Health News:NYC teens and young adults who abuse prescription at high risk for overdose 2Health News:NYC teens and young adults who abuse prescription at high risk for overdose 3Health News:How genes link a mother's diet to the risk of obesity in her offspring 2Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2Health News:Family conflicts, other non-physical worries before cancer surgery raise patients' complication risk 2
... time you load on the sauce, onto your pizza or spaghetti, ... ones//. , Scientists from Ohio State University have ... tomatoes, is absorbed better by the body, when it comes from ... study is published in the Journal of Agricultural and Food Chemistry. ...
... Defense Services will be bound by a Supreme Court order ... fired due to their health condition. , ,Last week ... soldiers and naval officers with HIV or AIDS. They could ... unsuitable for work. ,Senior officials in the army ...
... that the hormone glucocorticoids may not be as beneficial ... prescribed by many specialists as a thrust to infertility ... glucocorticoids are employed by many specialists to treat infertility, ... responses in a good manner. They are used to ...
... Remanence of anthrax spores in Smailholm and the border ... a decontamination operation// at a village hall where drumming ... deputed the New York-based specialists Sabre, to look into ... of anthrax evident in certain areas in Northumberland and ...
... accident that left a father and young daughter dead in ... ,Two people were killed Monday after the single-engine ... a small local airport in Bedford - into the home ... of the former mother-in-law of the divorced 47-year-old pilot, The ...
... who was seen visibly limping at a film awards function ... film 'Drona' in Bikaner last month. ,'She ... ignored it and kept shooting right through the injury. Because ... Filmfare awards show and even in parliament,' Amitabh Bachchan, Jaya's ...
Cached Medicine News:Health News:Pass the Orange Tomato Sauce Please 2
The True Non-Compliant Balloon....
... Jude Medical® Pacing System Analyzer (PSA Wand), ... implantation testing, programming and interrogation of bradycardia ... easy-to-use accessory to the St. Jude Medical ... obtaining measurements of intrinsic P- and R-wave ...
... The Finnpipette BioControl multichannel ... features as the single ... handle fits all seven ... channel tip cone modules. ...
... Long series in colonies, rows, and microplatesthat ... the multichannel pipette is becoming an ever-increasing ... use) was the main reason that the ... 8- or 12-channel pipette provides effective, precise, ...
Medicine Products: